InvestorsHub Logo
icon url

sukus

11/25/19 9:27 PM

#253332 RE: Umibe5690 #253322

I happened to see that is the modus operandi perhaps to suppress the pps to 20% or 25%. FRAN happened to behave similar to this before quadrupled. No wonder investing is so much difficult. Happened to my small gold and silver companies in early 2017 which were suppressed to 20%. We didn’t realize it until they were in the rear view mirror. Just my two cents.
icon url

H2R

11/25/19 9:47 PM

#253337 RE: Umibe5690 #253322

Hi Umibe5690,

If I read you correctly, you write that with good TLD, the jump would be from $0.22 to about $0.88. That's market cap of, say, $500M-$600M. While $0.88 would be quite nice, I believe that's an underestimation.

Since we are guessing, I would guess the valuation using whatever form you'd like for a treatment with few if any SAE for an unmet medical need around Cancer and a platform potential would be substantially higher, more in the multi-billion. My guess would be a valuation of at least $5B after the market takes in the full implication of DC-Vax's potential.

Best of luck to Patients, NWBO, and Longs!